“This research has been maturing as our tools improve. The first published report of the procedure in the Islet Cell Transplant database is 1999 according to the National Library of Medicine. I expect there will be more improvements.” Bill Chesnut, MD.
To go back to New Health News: http://billchesnutmd.com/new-health-news
Transplants of insulin-producing pancreas cells may help the most seriously ill patients with diabetes. Ama Wire, April 19, 2016.
The AP (4/19, Neergaard) reports that “transplants of insulin-producing pancreas cells” may help “protect the most seriously ill patients” with diabetes “from a life-threatening complication of the disease,” severe hypoglycemia, the findings of a study published online April 18 in Diabetes Care suggest. For the study, “the National Institutes of Health targeted…highest-risk patients, funding a study that gave 48 people at eight medical centers at least one islet cell transplant.” Just one year after transplant, “88 percent were free of severe hypoglycemia events, had their awareness of blood sugar dips restored, and harbored glucose levels in near-normal ranges,” and “two years later, 71 percent of participants still were faring that well,” the study found. The study team now “plans to seek a Food and Drug Administration license for” cell-based diabetes therapy.